1. Cutaneous Involvement in Waldenström's Macroglobulinaemia.
- Author
-
Stien S, Durot E, Durlach A, Beylot-Barry M, Adamski H, Beltraminelli H, Bohelay G, Carlotti A, Carpentier O, Cornillet P, Dubois R, Franck N, Husson B, Laroche L, Maubec E, le Clech C, Machet L, Ortonne N, Ram-Wolff C, Vergier B, and Grange F
- Subjects
- Humans, Mutation, Myeloid Differentiation Factor 88 genetics, Retrospective Studies, Skin, Waldenstrom Macroglobulinemia diagnosis, Waldenstrom Macroglobulinemia genetics
- Abstract
Cutaneous involvement in Waldenström's macroglobulinaemia (WM) has been poorly characterized. To describe this involvement, a retrospective study of 19 patients with WM and cutaneous involvement of tumour B cells was performed. Twelve patients (group 1) had lymphoplasmacytic, non-transformed cutaneous proliferation, while in 7 cases (group 2) cutaneous involvement corresponded to histological transformation. In group 1, skin involvement was inaugural in 6 cases. The lesions were infiltrated plaques (83%), papules (25%) and tumours (42%). Four patients had a similar clinical picture (purplish, bilateral and symmetrical infiltration on the face). MYD88 L265P mutation was detected in the skin biopsy in all 6 cases tested. The 3-year specific survival rate was 88%. In group 2, cutaneous transformation occurred during the follow-up of the WM (71%). Lesions presented as ulcerated tumours (86%) of the trunk (57%) and lower limbs (57%). The 3-year specific survival rate was 22%. Skin involvement in WM has distinctive characteristics (e.g. clinical, histological, immunohistochemical, MYD88 L265P mutation).
- Published
- 2020
- Full Text
- View/download PDF